HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,370,000 | -72.3% | 1,227,000 | -83.5% | 0.00% | -50.0% |
| Q1 2020 | $8,571,000 | +22.0% | 7,437,000 | +40.2% | 0.00% | 0.0% |
| Q4 2019 | $7,023,000 | -10.1% | 5,303,000 | -20.5% | 0.00% | 0.0% |
| Q3 2019 | $7,810,000 | +64.8% | 6,674,000 | +56.2% | 0.00% | +100.0% |
| Q2 2019 | $4,738,000 | -56.0% | 4,274,000 | -54.9% | 0.00% | -66.7% |
| Q1 2019 | $10,762,000 | +287.3% | 9,484,000 | +237.9% | 0.00% | +200.0% |
| Q4 2018 | $2,779,000 | -0.6% | 2,807,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,796,000 | -33.6% | 2,807,000 | -36.0% | 0.00% | 0.0% |
| Q2 2018 | $4,213,000 | +56.6% | 4,383,000 | +49.8% | 0.00% | 0.0% |
| Q1 2018 | $2,691,000 | -0.3% | 2,925,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,698,000 | +2.2% | 2,925,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,640,000 | -25.7% | 2,925,000 | -28.9% | 0.00% | 0.0% |
| Q2 2017 | $3,553,000 | -24.8% | 4,113,000 | -20.1% | 0.00% | 0.0% |
| Q1 2017 | $4,724,000 | -3.6% | 5,148,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,898,000 | – | 5,148,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|